MORGAN STANLEY PLC/PUT/REVVITY/75/0.1/20.09.24

MORGAN STANLEY PLC/PUT/REVVITY/75/0.1/20.09.24 Stock

DE000ME2W498

Market Closed - Börse Stuttgart 02:33:54 2024-06-13 pm EDT
0.101 ^EUR	+12.22%

Current month	-11.40%
1 month	-12.17%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart REVVITY, INC.

Chart MORGAN STANLEY PLC/PUT/REVVITY/75/0.1/20.09.24

Latest news about REVVITY, INC.

Transcript : Revvity, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM	Jun. 10
Revvity to Present at Goldman Sachs Global Healthcare Conference	May. 28	BU
Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM	May. 14
Revvity : Q1 2024 Earnings Transcript	Apr. 30	PU

More news

Quotes 5-day view

Date	Price	Change
24-06-13	0.101	+12.22%
24-06-12	0.09	-18.92%
24-06-11	0.111	0.00%
24-06-10	0.111	0.00%
24-06-07	0.111	+0.91%

Delayed Quote Börse Stuttgart

Last update June 13, 2024 at 02:33 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	REVVITY, INC.
Issuer	Morgan Stanley
WKN	ME2W49
ISIN	DE000ME2W498
Date issued	2023-11-01
Strike	75 $
Maturity	2024-09-20 (99 Days)
Parity	10 : 1
Emission price	0.7 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.94 €
Lowest since issue	0.063 €
Spread	0.058 €
Spread %	36.94%

Company Profile

Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows: - medical diagnosis equipment (61%); - analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).

Sector

More about the company

Ratings for Revvity, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Consensus: Revvity, Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

110.7 USD

Average target price

124.1 USD

Spread / Average Target

+12.09%

Consensus